Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Invested Capital (2024 - 2025)

Tg Therapeutics has reported Return on Invested Capital over the past 2 years, most recently at 191.14% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 191.14% for Q4 2025, down 19116.0% from a year ago — trailing twelve months through Dec 2025 was 191.14% (down 19116.0% YoY), and the annual figure for FY2025 was 275.62%, down 27564.0%.
  • Return on Invested Capital for Q4 2025 was 191.14% at Tg Therapeutics, down from 0.76% in the prior quarter.
  • Over the last five years, Return on Invested Capital for TGTX hit a ceiling of 0.76% in Q3 2025 and a floor of 191.14% in Q4 2025.